Fund managers rushed to boost their portfolios that will be presented to clients at the end of the quarter.

A lot of pharmaceutical companies have hired compliance managers to make sure that all aspects of a meeting are compliant. In many cases, a company's internal guidelines are even more stringent than those of the Pharmaceutical Research and Manufacturers of America, Food & Drug Administration, and Office of Inspector General.

It's time to take profit as the market rose for most of the last two weeks.

It's quarter-end. Everybody is now trying to make their portfolios look handsome (with window dressing).

Technically, these stocks are due for a rebound after being oversold last month.

There is a knee-jerk reaction to this short-term political concern. But should foreign investors realize that this is not for the short term, they may be prompted to sell as well.